WallStreetZenWallStreetZen

NASDAQ: HALO
Halozyme Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for HALO

Based on 6 analysts offering 12 month price targets for Halozyme Therapeutics Inc.
Min Forecast
$40.00-12.05%
Avg Forecast
$54.00+18.73%
Max Forecast
$71.00+56.11%

Should I buy or sell HALO stock?

Based on 6 analysts offering ratings for Halozyme Therapeutics Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
3 analysts 50%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HALO stock forecasts and price targets.

HALO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-22
lockedlocked$00.00+00.00%2024-05-08
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2024-01-18
Morgan Stanley
Bottom 5%
5
Strong BuyMaintains$59.00+29.73%2023-12-26

1 of 1

Forecast return on equity

Is HALO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
28.09%

Forecast return on assets

Is HALO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

HALO revenue forecast

What is HALO's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$952.8M+10.41%
Avg 2 year Forecast
$1.1B+28.38%
Avg 3 year Forecast
$1.3B+50.71%
HALO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HALO earnings growth forecast

How is HALO forecast to perform vs Biotechnology companies and vs the US market?
Company
41.76%
Industry
9.1%
Market
18.22%
HALO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HALO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HALO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HALO revenue growth forecast

How is HALO forecast to perform vs Biotechnology companies and vs the US market?
Company
14.41%
Industry
36.33%
Market
10.01%
HALO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HALO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HALO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HALO$45.48$54.00+18.73%Buy
IONS$38.00$64.63+70.07%Buy
BBIO$29.27$49.14+67.90%Strong Buy
EXEL$21.00$26.78+27.51%Buy
CYTK$59.23$95.00+60.39%Buy

Halozyme Therapeutics Stock Forecast FAQ

Is Halozyme Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: HALO) stock is to Buy HALO stock.

Out of 6 analysts, 2 (33.33%) are recommending HALO as a Strong Buy, 3 (50%) are recommending HALO as a Buy, 1 (16.67%) are recommending HALO as a Hold, 0 (0%) are recommending HALO as a Sell, and 0 (0%) are recommending HALO as a Strong Sell.

If you're new to stock investing, here's how to buy Halozyme Therapeutics stock.

What is HALO's revenue growth forecast for 2024-2026?

(NASDAQ: HALO) Halozyme Therapeutics's forecast annual revenue growth rate of 14.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.33%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.01%.

Halozyme Therapeutics's revenue in 2024 is $862,989,000.On average, 5 Wall Street analysts forecast HALO's revenue for 2024 to be $121,268,067,214, with the lowest HALO revenue forecast at $120,660,842,960, and the highest HALO revenue forecast at $121,852,127,600. On average, 6 Wall Street analysts forecast HALO's revenue for 2025 to be $141,012,210,108, with the lowest HALO revenue forecast at $135,062,786,978, and the highest HALO revenue forecast at $153,298,987,520.

In 2026, HALO is forecast to generate $165,539,055,374 in revenue, with the lowest revenue forecast at $162,482,442,990 and the highest revenue forecast at $169,414,421,400.

What is HALO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: HALO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is HALO's Price Target?

According to 6 Wall Street analysts that have issued a 1 year HALO price target, the average HALO price target is $54.00, with the highest HALO stock price forecast at $71.00 and the lowest HALO stock price forecast at $40.00.

On average, Wall Street analysts predict that Halozyme Therapeutics's share price could reach $54.00 by May 22, 2025. The average Halozyme Therapeutics stock price prediction forecasts a potential upside of 18.73% from the current HALO share price of $45.48.

What is HALO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: HALO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.